Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Study of the Effect of Microneedle Lesion Preparation, Incubation Time and Light Power Density on Photodynamic Therapy With Levulan Kerastick (Aminolevulinic Acid HCl) for Topical Solution, 20% + Blue Light for the Field Treatment of Actinic Keratoses on the Face

NCT02632110 is registered in ClinicalTrials.gov with DUSA Pharmaceuticals, Inc. as lead sponsor.

NCT NCT02632110
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02632110 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Study of the Effect of Microneedle Lesion Preparation, Incubation Time and Light Power Density on Photodynamic Therapy With Levulan Kerastick (Aminolevulinic Acid HCl) for Topical Solution, 20% + Blue Light for the Field Treatment of Actinic Keratoses on the Face
Lead sponsor
DUSA Pharmaceuticals, Inc.
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2016
Completion date
September 12, 2016
Enrollment
137 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

actinic keratosis